Schizophrenia is a difficult condition for patients and their families to manage. Relapse is a frequent occurrence, particularly if patients decide to discontinue antipsychotic drug treatment because of unwanted side effects. Psychiatrists say over half of patients relapse within two years and over 80 per cent within five years. Relapse is five times more likely to occur among patients who stop their treatment.
Home » Psychology news » New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Presented At ECNP
New Antipsychotic Drug Asenapine (Saphris) Helps Prevent Relapse In People With Schizophrenia; Phase III Data Presented At ECNP
September 18, 2009 by NewsBot


